South Korean Pharmaceuticals & Biotech Strong Balance Sheet Stocks

BIOBIJOULtd

Market Cap: ₩244.0b

Engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea.

Optipharm.CO.LTD

Market Cap: ₩75.4b

Operates as a biomedical solution provider in South Korea.

Genome

Market Cap: ₩81.1b

A clinical stage biotechnology company, researches and develops novel-targeted immuno-oncology therapeutics in the field of immuno-oncology, skin diseases, and autism in South Korea.

Psomagen

Market Cap: ₩72.0b

Engages in the provision omics solutions and contract laboratory services.

WooGene B&G

Market Cap: ₩26.9b

Engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally.

Jeil Pharma Holdings

Market Cap: ₩133.2b

Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.

ViGenCell

Market Cap: ₩80.8b

Specializes in immune cell therapy.

ISU Abxis

Market Cap: ₩215.0b

A biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide.

Aligned Genetics

Market Cap: ₩47.0b

Offers cellular imaging and biomolecular analysis solutions worldwide.

GENINUS

Market Cap: ₩69.2b

A bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea.

PharmaResearch

Market Cap: ₩5.7t

Operates as a biopharmaceutical company primarily in South Korea.

Seegene

Market Cap: ₩1.2t

Manufactures and sells molecular diagnostics products worldwide.

WITHUS PHARMACEUTICALLTD

Market Cap: ₩92.8b

Engages in the production and sale of pharmaceutical products in South Korea.

APTOCROM

Market Cap: ₩73.5b

Distributes pharmaceutical products in South Korea.

TiumBio

Market Cap: ₩154.2b

A drug discovery company, researches and develops therapeutics for patients with unaddressed rare diseases.

Oscotec

Market Cap: ₩1.7t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

Chong Kun Dang Pharmaceutical

Market Cap: ₩1.1t

Engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.

Bukwang Pharmaceutical

Market Cap: ₩357.2b

Develops, produces, and sells pharmaceutical products in South Korea and internationally.

NIBEC

Market Cap: ₩307.0b

A healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.

TegoScience

Market Cap: ₩144.8b

A biotechnology-based cosmetics company, engages in the production and sale of skin cell therapy products from human epithelial cells in South Korea.

Quratis

Market Cap: ₩72.3b

Engages in developing vaccines in South Korea.

DK Life Science

Market Cap: ₩134.5b

A pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea, the European Union, Japan, and internationally.

Genolution

Market Cap: ₩42.8b

Manufactures and sells IVD products in South Korea and internationally.

Organoidsciences

Market Cap: ₩246.5b

Develops regenerative therapies in South Korea.

NeoImmuneTech

Market Cap: ₩79.2b

A clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics.

curacleltd

Market Cap: ₩87.1b

Curacle Co., Ltd., a bio-venture business, engages in the research and development of drugs for diseases caused by aging process and damage to blood vessels.

S.Biomedics

Market Cap: ₩294.7b

S.Biomedics CO., LTD., a biopharmaceutical company, engages in the research and development of stem cells therapy products.

Mezzion PharmaLtd

Market Cap: ₩2.0t

Develops, manufactures, and sells pharmaceutical products in South Korea.

Genomictree

Market Cap: ₩544.0b

A biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases.

J2KBIO

Market Cap: ₩55.1b

A bio venture company, provides active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation.

PharmAbcine

Market Cap: ₩88.0b

PharmAbcine Inc., a clinical-stage biotech company, develops human therapeutic monoclonal antibody (mAb) for the treatment of neovascular disorders, tumors, and other medically unmet diseases.

Daewoong

Market Cap: ₩930.3b

Engages in the manufacture and sale of pharmaceuticals in South Korea.

Kyung Nam PharmLtd

Market Cap: ₩47.7b

Engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia.

BNC Korea

Market Cap: ₩346.1b

Engages in the research and development, production, and sale of biomaterials for medicines in South Korea.

Sam-A Pharm

Market Cap: ₩103.1b

Operates as a pharmaceutical company in South Korea.

Huons

Market Cap: ₩355.4b

Provides medical solutions for human health in Korea and internationally.